Corporate GovernanceMay 15, 2026, 06:31 AM
Galera Therapeutics Increases Authorized Shares to 400M, Adds Written Consent
AI Summary
Galera Therapeutics, Inc. has amended its Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200 million to 400 million. Additionally, the company filed an amendment to provide stockholders with the right to act by written consent. Both charter amendments were approved by stockholders at the Annual Meeting on May 8, 2026, and the Board of Directors also adopted Amended and Restated Bylaws consistent with the written consent right.
Key Highlights
- Galera Therapeutics increased authorized common stock from 200 million to 400 million shares.
- Stockholders approved the increase in authorized shares at the Annual Meeting on May 8, 2026.
- The company filed the Stock Increase Charter Amendment on May 11, 2026.
- Stockholders were granted the right to act by written consent.
- The Written Consent Charter Amendment was filed on May 12, 2026.
- Amended and Restated Bylaws, effective May 12, 2026, also provide for written consent rights.
Price Impact
More from GRTX